The improvement of hepatic steatosis and presumably inflammation is likely due to activation of GLP-1R on hepatocytes, because others have shown that exenatide stimulates hepatocyte expression of PPARα and PPARγ that improve hepatic fatty acid oxidation, lipid export, and insulin sensitivity [33]. Here, PPARG is linked to fatty liver disease.